伝統医薬データベース　

サイト内検索結果「」

全16,951件中、3,081件～3,100件を表示しています。
[1] ・・・ [150] [151] [152] [153] [154] [155] [156] [157] [158] [159] [160] ・・・ [848]

Aristlochic acid 腸内細菌 Unable to generate chemical name,Aristolochic Acid B,Unable to generate chemical name,Unable to generate chemical name,Unable to generate chemical name,Unable to generate chemica

6162. [生薬成分の代謝] 代謝マップ『Berberine』

Berberine ラット male Wistar rats Berberine,Berberrubine,Thalifendine,Demethyleneberberine,Jatrorrhizine Oral administration,Oral administration,Oral administration,Oral administration,Oral administratio

6163. [生薬成分の代謝] 代謝マップ『Ganoderic Acid A』

Ganoderic Acid A 動物 Ganoderic acid A Intravenous administration,Intravenous administration,Oral administration,Oral administration 1) Gao J. J., Min B. S., Akao T., Meselhy M. R., and Hattori M.: En

6164. [生薬成分の代謝] 代謝マップ『Ganoderiol F』

Ganoderiol F ヒトおよびラット腸内細菌動物　ラット Ganoderiol F,Ganodermatriol Intravenous administration,Oral administration,Oral administration 19407927 1) Zhang Q., Zuo F. Nakamura N., Ma C. M., and Hattori M.: Meta

6165. [生薬成分の代謝] 代謝マップ『Pinoresinol diglucoside』

Pinoresinol diglucoside 腸内細菌　Enterococcus faecalis strain PDG Pinoresinol diglucoside,(+)-Lariciresinol 12736449 1) Xie L., Akao T., Hamasaki K., Deyama T. and Hattori M.: Biotransformation of pinore

6166. [生薬成分の代謝] 代謝マップ『Ergosterol Peroxide』

Ergosterol Peroxide ヒト及びラット腸内細菌フローラ Ergosterol peroxide,(3S,4aR,5aS,6S,9R,9aR,11bR)-9-((2R,5R,E)-5,6-dimethylhept-3-en-2-yl)-9a,11b-dimethyl-1,2,3,4,5a,6,7,8,9,9a,10,11,11a,11b-tetradecahydrocyclopent

6167. [生薬成分の代謝] 代謝マップ『Salicin』

Salicin ラット Salicylic acid glucoside,Saligenin,Salicin,Salicylic acid 12221594 1) Akao T., Yoshino T., Kobashi K. and Hattori M.: Evaluation of salicin as an antipyretic prodrug that does not cause g

6168. [生薬成分の代謝] 代謝マップ『Strychinine N』

Strychinine N ヒト腸内細菌株 Lactobacillus acidophilus Strychnine,Strychinine N-oxide,16-Hydroxystrychine 8103941 1) El-Mekkawy S., Meselhy M. R., Kawata Y., Kadota S., Hattori M., and Namba T.: Metabolism

6169. [生薬成分の代謝] 代謝パラメータ『Oral administration』

Oral administration 40 mg/kg 9.53 ± 3.2 h ^a 253.2 ± 124.5 ng∙h∙ml^-1 ^b 0-limit 10.9 ± 2.4 h ^a 1.71 ± 0.8 h a p< 0.05, b p< 0.01 compared with conventional rats; Data are expressed as

6170. [生薬成分の代謝] 代謝マップ『Sweroside』

Sweroside ヒト腸内細菌フローラ、ヒト腸内細菌株 Proteus mirabilis Naucledal,Sweroside,(4aS,5R,6R)-6-hydroxy-5-vinyl-4,4a,5,6-tetrahydropyrano[3,4-c]pyran-1(3H)-one,2-((S,E)-3-(hydroxymethylene)-2-oxotetrahydro-2H-pyran-

6171. [生薬成分の代謝] 代謝マップ『Benzoylaconine』

Benzoylaconine ラット Aconitine,Benzoylaconine 12951473 1) Tazawa T., Zhao H., Li Y., Meselhy M. R., Nakamura N., Akao T. and Hattori M.: A new enzyme immunoassay for aconitine and its application to qu

6172. [生薬成分の代謝] 代謝マップ『Benzoylmesaconine』

Benzoylmesaconine ラット Mesaconitine,Benzoylmesaconine Intravenous administration,Intravenous administration,Oral administration,Oral administration 1) Zuo F., Zhao J., Nakamura N., Gao J. J., Akao T.,

6173. [生薬成分の代謝] 代謝マップ『Cycasin』

Cycasin methyldiazene,Cycasin,Methylazoxymethanol,Diazomethane 1) Drasar B. S. and Hill M. J., Human Intestinal Flora, pp. 62-65, Academic Press, London・New York・Sanfrancisco, 1974. 生薬成分の代謝マップ

6174. [生薬成分の代謝] 代謝物『Mesaconitine』

(3R,4R,8R,9R,10R,11S,11aR)-11a-acetoxy-4,9,11-trihydroxy-6,10,13-trimethoxy-3-(methoxymethyl)-1-methyltetradecahydro-1H-3,6a,12-(epiethane[1,1,2]triyl)-7,9-methanonaphtho[2,3-b]azocin-8-yl benzoate Me

6175. [生薬成分の代謝] 代謝マップ『Cholic acid』

Cholic acid Cholic acid,(R)-4-((3R,5S,7R,8R,9S,10S,13R,14S,17R)-3,7-dihydroxy-10,13-dimethylhexadecahydro-1H-cyclopenta[a]phenanthren-17-yl)pentanoic acid,(R)-4-((5R,7R,8R,9S,10S,13R,14S,17R)-7-hydro

6176. [生薬成分の代謝] 代謝物『Albiflorin』

((1R,3R,4R,6S,9S)-4-hydroxy-6-methyl-8-oxo-1-(((2R,3R,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-yl)oxy)-7-oxatricyclo[4.3.0.03,9]nonan-9-yl)methyl benzoate Albiflorin 39011-90-0 C

6177. [生薬成分の代謝] 代謝物『Precatorin II』

6-((2S,3R,4S,5S,6R)-3-(((2S,3R,4R)-3,4-dihydroxy-4-(hydroxymethyl)tetrahydrofuran-2-yl)oxy)-4,5-dihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-yl)-5-hydroxy-2-(4-hydroxyphenyl)-7,8-dimethoxy-4H-chro

6178. [生薬成分の代謝] 代謝物『Rhein』

4,5-dihydroxy-9,10-dioxo-9,10-dihydroanthracene-2-carboxylic acid Rhein 478-43-3 C15H8O6 284.225 284.0321 285.0399 283.0243 Rhein 代謝物

6179. [生薬成分の代謝] 代謝物『Gardenoside』

1-((1S,4aS,7S,7aS)-7-hydroxy-7-(hydroxymethyl)-1-(((3S,5R,6S)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-yl)oxy)-1,4a,7,7a-tetrahydrocyclopenta[c]pyran-4-yl)ethanone Gardenoside 24512-62-

6180. [生薬成分の代謝] 代謝マップ『Mesaconitine』

Mesaconitine Wistarラット Mesaconitine,Benzoylmesaconine,Mesaconine Intravenous administration,Oral administration 18778973 1) Zhao Z., Sun X. F., Nakamura N., Zuo F., Yang X. W., and Hattori M.: Develop

[1] ・・・ [150] [151] [152] [153] [154] [155] [156] [157] [158] [159] [160] ・・・ [848]
全16,951件中、3,081件～3,100件を表示しています。

ページの上へ戻る

TOPICS

生薬

漢方

試験薬物

遺伝子解析情報

化学分析情報

活性試験情報

生薬成分の代謝情報

探索研究